Business Wire

Mobileum and NOHOLD Launch Strategic AI Alliance to Transform Telecom Data Monetization and Redefine Telecom Ecosystems

2.9.2025 09:00:00 CEST | Business Wire | Press release

Share

Mobileum Inc. (“Mobileum”), a leading global provider of analytics and network solutions, and NOHOLD, a pioneer in AI-powered automation solutions, today announced the formation of a strategic alliance to redefine AI enablement across the telecom industry. This partnership marks a major step forward in building a scalable AI ecosystem that seamlessly blends into multi-vendor telecom operations, empowering operators to unlock the full value of their data.

As telcos race to modernize operations and monetize growing volumes of customer and network data, the Mobileum-NOHOLD alliance aims to simplify and accelerate AI adoption by communication service providers across increasingly complex environments. The joint initiative will deliver seamless AI-powered support solutions capable of ingesting and interpreting data from heterogeneous systems, enabling better alignment between customer needs and the reality of modern network services, analytics platforms, and 5G infrastructure.

“As telecom ecosystems become more complex, delivering fast, effective support has never been more critical. This alliance brings AI to the forefront of the telecom experience, helping providers resolve issues more intelligently and efficiently while reducing complexity for both customers and internal teams. We are excited to partner with Mobileum and deliver meaningful value to the industry together,” said Diego Ventura, CEO and Founder at NOHOLD.

A Unified Framework for Intelligent, Multi-Vendor Collaboration

At the core of the alliance is a shared AI framework that connects telecom providers, technology partners, and sales and support leaders. This framework enables interoperability between AI assistants across vendors and systems, resolving long-standing support challenges that arise when multiple vendors are involved in delivering a discrete solution. It provides deeper insights into users’ needs and opportunities to continuously improve their experience. Whether it’s a mobile operator supporting an enterprise IoT deployment or seeking to develop a personalized customer journey, this AI ecosystem delivers context-aware, cross-domain support by connecting network insights with customer-facing services, without requiring the development of in-house bespoke solutions. This approach is especially critical in telecom environments where multiple technology providers must coordinate to deliver a unified experience.

“Mobileum has been a driver of telecom innovation for the last 25 years,” said Miguel Caramés, Chief Product Officer at Mobileum. “We see Generative AI and Intelligent Agents as the next frontier, not just for automation, but for creating entirely new revenue opportunities from telecom data. This alliance with NOHOLD allows us to bring this vision to market with agility, scale, and impact.”

Enabling the Next Wave of Telecom Data Monetization

The alliance will equip telecom operators with the tools to:

  • Leverage Mobileum’s experience and expertise in interoperability and integration across different technology stacks, multi-vendor solutions and complex global solutions that work across operator boundaries
  • Monetize data by embedding AI-driven insights into enterprise services
  • Deploy AI assistants that scale across consumer and B2B segments
  • Accelerate resolution and upsell opportunities through intelligent support automation
  • Unify data silos across vendors, systems and domains for holistic decision making

This alliance will lay the foundation for a telecom-native AI ecosystem, one that goes beyond cost efficiency to unlock new value streams through personalized, data-driven services for enterprises and subscribers.

Mobileum and NOHOLD invite other telecom and tech leaders to join the alliance and shape the future of scalable, intelligent support and automation across the telecom industry.

About Mobileum Inc.

Mobileum is a leading provider of Telecom analytics solutions for roaming, core network, security, risk management, domestic and international connectivity testing, and customer intelligence. More than 1,000 customers rely on its Active Intelligence platform, which provides advanced analytics solutions, allowing customers to connect deep network and operational intelligence with real-time actions that increase revenue, improve customer experience, and reduce costs. Headquartered in Silicon Valley, Mobileum has global offices in Australia, Germany, Greece, India, Japan, Portugal, Singapore, UK, and United Arab Emirates. Learn more at www.mobileum.com

About NOHOLD

NOHOLD, Inc. is a Silicon Valley–based pioneer of enterprise-grade AI, delivering interactive and diagnostic virtual assistants via its award‑winning SICURA® platform. Since its founding in 1999, the company has partnered with Fortune 500 organizations worldwide—spanning financial services, healthcare, HR, education, and more—to streamline customer and employee experiences, reduce reliance on traditional call centers, and drive measurable ROI through intelligent automation. Backed by four granted patents and annual SOC 2 Type II / HIPAA compliance audits, NOHOLD has built over 1,400 AI Assistants that deliver secure, scalable self‑service, handling sensitive data with enterprise-grade trust. With two decades of expertise and a global footprint, the NOHOLD AI Alliance™ continues empowering enterprises to elevate digital service experiences through responsible, next‑generation AI. More information can be found at www.nohold.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250902358556/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse

Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye